Gov. Jared Polis announced Tuesday that the Food and Drug Administration has signed off on Colorado’s plan to import certain prescription drugs from Canada, moving the state closer to offering lower-cost versions of several high-priced medications. Polis called the federal signoff “the vital first step” and urged drugmakers to stop inflating prices and put people before profit.
FDA Signs Off on Colorado’s Section 804 Plan
The authorization arrived in a June 15 letter from the Food and Drug Administration stating that Colorado’s Section 804 State Importation Program meets statutory requirements and approving the state’s application for an initial two-year period. The letter spells out a series of conditions, including pre-import filings, statutory testing for authenticity and degradation, relabeling, and formal electronic import entries that the state and its vendors must satisfy before any shipment can land in Colorado pharmacies. Those details are laid out in the Food and Drug Administration letter.
Drugs on the List and Projected Savings
Colorado’s application targets 16 drugs covering 20 drug strength combinations, including widely used and often pricey medications such as Eliquis, Ozempic, Januvia, and Trikafta. The state’s actuarial appendix projects about 46.2 million dollars in savings over the first three years if the program hits its expected participation levels. The savings projections and selected drug list are detailed in state filings, including the appendix from the Colorado Department of Health Care Policy & Financing, as well as coverage from Colorado Public Radio.
How the Pipeline Will Work
Under Food and Drug Administration rules, a designated importer must file a Pre-Import Request at least 30 calendar days before a shipment is scheduled to arrive, and the agency has to approve that request before any drugs cross the border. The program must also include testing plans that verify drug authenticity and integrity, validated lab testing in the United States, and compliant labeling before anything is distributed to pharmacies. Those procedural steps and regulatory guardrails are outlined in Food and Drug Administration guidance for Section 804 importation programs.
Diplomatic and Industry Hurdles
Canada has repeatedly warned it will act to protect its domestic drug supply and already has regulations that restrict exports if they could worsen shortages, a constraint Colorado will have to navigate. The pharmaceutical industry has raised safety and supply concerns in past importation debates, and Florida’s earlier authorization came with political and logistical complications that now stand as a cautionary example. For background on those tensions, see statements from Health Canada and Associated Press coverage.
What Comes Next
Polis and state officials say they will now work with the vendor network named in the application, along with willing manufacturers, to submit pre-import requests, set up testing and relabeling operations, and move toward actual shipments once the Food and Drug Administration grants specific pre-import approvals. In a Facebook post, the governor framed the authorization as a critical milestone and said some drugs could become available as soon as next year, provided manufacturers participate, and Canadian supplies line up as planned.
